Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccine.
Gigliotti
F
F
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis.
Feldman
S
S
Wang
W C
WC
Day
S W
SW
Brunson
G
G
D000367:Age Factors; D000755:Anemia, Sickle Cell / Q000150:complications*; D000907:Antibodies, Bacterial / Q000032:analysis; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D004168:Diphtheria Toxoid / Q000008:administration & dosage*; D005069:Evaluation Studies as Topic; D005260:Female; D006192:Haemophilus Infections / Q000517:prevention & control*; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology; D006450:Hemoglobin SC Disease / Q000150:complications; D006801:Humans; D007114:Immunization; D007074:Immunoglobulin G / Q000032:analysis; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D013789:Thalassemia / Q000150:complications
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D004168:Diphtheria Toxoid; D018073:Haemophilus Vaccines; C052180:Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate; D007074:Immunoglobulin G